Compass Pathways PLC (CMPS)
6.69
+0.03
(+0.45%)
USD |
NASDAQ |
Jun 17, 10:01
Compass Pathways Net Income (Quarterly): -35.19M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -35.19M |
December 31, 2023 | -32.53M |
September 30, 2023 | -33.39M |
June 30, 2023 | -28.34M |
March 31, 2023 | -24.21M |
December 31, 2022 | -30.93M |
September 30, 2022 | -18.37M |
June 30, 2022 | -21.04M |
March 31, 2022 | -21.17M |
December 31, 2021 | -25.65M |
Date | Value |
---|---|
September 30, 2021 | -15.85M |
June 30, 2021 | -17.53M |
March 31, 2021 | -12.72M |
December 31, 2020 | -18.81M |
September 30, 2020 | -16.69M |
June 30, 2020 | -16.25M |
March 31, 2020 | -8.585M |
December 31, 2019 | -7.635M |
September 30, 2019 | -5.68M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-35.19M
Minimum
Mar 2024
-5.68M
Maximum
Sep 2019
-20.56M
Average
-18.81M
Median
Dec 2020
Net Income (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | -48.50M |
Biodexa Pharmaceuticals Plc | -- |
Verona Pharma PLC | -25.79M |
NuCana PLC | -8.673M |
Autolus Therapeutics PLC | -52.69M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 35.47M |
EPS Diluted (Quarterly) | -0.55 |
Enterprise Value | 221.62M |
Earnings Yield | -35.06% |